
Jill Davies
CEO of Genome Medical; board-certified genetic counselor
South San Francisco, California
Summary
Clinical leader in telehealth genomics: Jill is a board-certified genetic counselor who built and scaled telehealth genetic counseling services — founding GeneMatters in 2016 and then leading integration into Genome Medical after its 2021 acquisition; she became Genome Medical's CEO in 2022 and has driven partnerships and enterprise programs to expand access to genetics across health systems, labs and life-science customers. genomemedical+2
Research and professional contribution to telegenetics: Jill has authored and co-authored peer-reviewed and conference research on telegenetics and digital triage tools (e.g., NSGC and J Genet Couns publications) and participates in clinical-genomics program design and validation work used to identify patients and quantify downstream clinical impact. nih+2
Product and partnership focus to scale access: Under her leadership Genome Medical has developed patient engagement and clinical support modules (e.g., RISE), and announced partnerships and programs with health systems and technology partners (e.g., Pierian, xCures, Gundersen) to operationalize genomic testing and counseling at scale. businesswire+2
Work
Education
Projects
Writing
Leveraging real-world data to assess downstream surgical uptake after genetic counseling (ASCO abstract e22551)
January 1, 2024ASCO meeting abstract describing use of real-world multi-institutional data to quantify bilateral mastectomy rates after genetic counseling; Jill Davies is an author representing Genome Medical.
Driving Growth and Expanding Downstream Service Opportunities with Virtual Genetic Services
August 1, 2023Q&A / thought piece by Jill Davies on the role of telehealth in expanding genetics care, workforce strategies (including Genetic Counseling Assistant roles), and how telehealth enables downstream service opportunities for health systems.
Genetic Counselors' Experiences and Interest in Telegenetics and Remote Counseling
January 1, 2018Survey study reporting genetic counselors' experiences, satisfaction and barriers with telehealth and telegenetics; includes contributions from Jill Davies (affiliated with GeneMatters at time of publication).